The Agency had conducted an inspection at Indoco's manufacturing facility for solid oral dosage form from 20 - 24 April 2023.

The EU GMP certification issued by the Health Authority from Malta confirms that the site complies with the Good Manufacturing Practice requirements as referred in the EC Directive.

The EU GMP certification will support supplies of drug products to Europe and other territories from this manufacturing site.